Bioqual, Inc. (BIOQ)

Bioqual Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Net Income	0.45	-1.05	0.48	0.84	5.26	6.33
Depreciation & Amortization	7.92	8	6.29	5.83	8.19	4.45
Stock-Based Compensation	-	-	-	-	-	0
Other Operating Activities	-2.15	-0.49	-0.26	-0.01	0.15	-0.41
Change in Accounts Receivable	3.02	0.69	6.8	6.12	-6.66	-5.66
Change in Accounts Payable	-0.34	0.52	-0.21	-1.7	1.18	-0.37
Change in Unearned Revenue	-1.61	0.29	-0.51	-0.21	0.29	0.05
Change in Income Taxes	-	-	-	-	-0.08	0.27
Change in Other Net Operating Assets	-1.94	-5.01	-3.22	-2.65	-8.02	-2.52
Operating Cash Flow	5.36	2.94	9.36	8.23	0.31	2.14
Operating Cash Flow Growth	133.16%	-68.53%	13.72%	2526.34%	-85.36%	-47.52%
Capital Expenditures	-0.36	-0.24	-0.6	-2.24	-4.89	-4.4
Sale of Property, Plant & Equipment	-	-	-	0	-	-
Other Investing Activities	-	-	-	-	0.15	0.71
Investing Cash Flow	-6.48	-0.24	-0.6	-2.24	-4.73	-3.69
Common Dividends Paid	-	-0.45	-0.45	-0.89	-1.12	-0.98
Financing Cash Flow	-	-0.45	-0.45	-0.89	-1.12	-0.98
Net Cash Flow	-1.13	2.26	8.31	5.1	-5.54	-2.54
Free Cash Flow	5	2.71	8.76	5.99	-4.57	-2.26
Free Cash Flow Growth	185.63%	-69.12%	46.34%	-	-	-
Free Cash Flow Margin	10.73%	5.54%	14.95%	9.55%	-6.91%	-3.92%
Free Cash Flow Per Share	5.58	3.03	9.80	6.69	-5.11	-2.53
Cash Income Tax Paid	0.06	0.06	0.07	1.46	2.31	2.34
Levered Free Cash Flow	10.84	8.73	12.3	9.33	0.92	0.2
Unlevered Free Cash Flow	10.84	8.73	12.3	9.33	0.92	0.2
Change in Working Capital	-0.87	-3.52	2.85	1.57	-13.28	-8.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.